2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1205360484 M.D.
Verify on CMS →

REZA ALIZADEH, M.D.

Glaucoma Specialist (Ophthalmology) Physician in SANTA MONICA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 648 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
60.0341/100
▼ 23 pts below national avg 83.1 · [object Object]
Industry payments
$268.05
8 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: REZA ALIZADEH, M.D. is a Glaucoma Specialist (Ophthalmology) Physician ([object Object]) practicing in SANTA MONICA, California with a Medicare Part D prescribing footprint of 2K claims across 648 beneficiaries — 43% brand-name prescribing . Their CMS MIPS Final Score of 60.0341/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $268.05 across 8 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: REZA ALIZADEH, M.D. reported a CMS MIPS final score of 60.0341 out of 100, below the 83.1 national average, and filed 2,062 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

REZA ALIZADEH, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

REZA ALIZADEH, M.D. at a glance

Below national average

NPI registry status

Active

Issued 04/14/2017

NPI 1205360484

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

2,062 30% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

60.0341/100 23.065899999999992% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Glaucoma Specialist (Ophthalmology) Physician share within California

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within California

Medicare quality performance — MIPS

REZA ALIZADEH, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

Below national average
MIPS Final Score
60.0341/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 60.0341/100 vs national avg 83.1

0%100%National avg83%60%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 60.0341/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

REZA ALIZADEH, M.D. is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in SANTA MONICA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1205360484. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

REZA ALIZADEH, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 1807 WILSHIRE BLVD STE 203, SANTA MONICA, CA, 90403, with a listed phone of (310) 829-0160. NPI 1205360484 was issued on 04/14/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALIZADEH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,062 prescription claims written by this provider, covering 648 Medicare beneficiaries and totaling roughly $217K in drug spend, split 43% brand-name and 57% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 60.0341/100 for the 2023 performance year (Quality 53.571, Cost 17.391), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1807 WILSHIRE BLVD STE 203
SANTA MONICA, CA 90403

Provider Details

NPI 1205360484
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 04/14/2017

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

60.0341
Final Score
Avg: 83.1
53.571
Quality
17.391
Cost
86
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where REZA ALIZADEH, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JULES STEIN EYE INSTITUTE MEDICAL GROUP
SANTA MONICA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for REZA ALIZADEH, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$268

Largest payer

Nova Eye, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to REZA ALIZADEH, M.D.. To verify REZA ALIZADEH, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

REZA ALIZADEH, M.D. — brand share 43.0%
Specialty average (est.)

43% brand-name claims vs 57% generic, on 2,062 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,062
Total Claims
$217K
Total Drug Cost
648
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,739
Total Day Supply
105,495
Brand vs Generic
43% brand / 57% generic
Brand Drug Cost
$182K
Generic Drug Cost
$35K

Patient Demographics

Average Patient Age
75.5 years
Avg HCC Risk Score
1.36
Gender Split
57% female / 43% male
Age Distribution
<65: 48, 65-74: 259, 75-84: 228, 85+: 113

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
501
Timolol Maleate
264
Brimonidine Tartrate
228
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
203
Prednisolone Acetate
146
Dorzolamide Hcl
110
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
104
Lumigan
Bimatoprost
83
Alphagan P
Brimonidine Tartrate
39
Simbrinza
Brinzolamide/Brimonidine Tart
38

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How REZA ALIZADEH, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

REZA ALIZADEH, M.D.'s 2,062 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ALIZADEH.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is REZA ALIZADEH, M.D.'s specialty?
REZA ALIZADEH, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in SANTA MONICA, California. Credentials: M.D..
How much does REZA ALIZADEH, M.D. prescribe under Medicare Part D?
In 2023, REZA ALIZADEH, M.D. wrote 2,062 Medicare Part D claims totaling $217K in drug costs for 648 beneficiaries.
What is REZA ALIZADEH, M.D.'s Medicare quality score?
REZA ALIZADEH, M.D. has a CMS MIPS Final Score of 60.0341/100 (Quality: 53.571, Cost: 17.391). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is REZA ALIZADEH, M.D. located?
REZA ALIZADEH, M.D. is located at 1807 WILSHIRE BLVD STE 203, SANTA MONICA, CA, 90403. Phone: (310) 829-0160.
What is REZA ALIZADEH, M.D.'s NPI number?
REZA ALIZADEH, M.D.'s National Provider Identifier (NPI) is 1205360484, issued on 04/14/2017.
Does REZA ALIZADEH, M.D. prescribe more brand-name or generic drugs?
REZA ALIZADEH, M.D.'s prescribing is 43% brand-name and 57% generic drugs by claim count, with $182K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does REZA ALIZADEH, M.D. prescribe most often?
Based on 2023 Medicare Part D data, REZA ALIZADEH, M.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does REZA ALIZADEH, M.D. accept Medicare?
REZA ALIZADEH, M.D. appears in CMS Medicare data with 2,062 Part D claims and 648 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify REZA ALIZADEH, M.D.'s credentials?
REZA ALIZADEH, M.D.'s NPI is 1205360484 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology